Multiple sclerosis

2,419,424views

Multiple sclerosis

CONA CM

CONA CM

Anemia: Clinical
Microcytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Myeloproliferative disorders: Pathology review
Myeloproliferative neoplasms: Clinical
Leukemias: Pathology review
Leukemia: Clinical
Lymphoma: Clinical
Plasma cell disorders: Pathology review
Plasma cell disorders: Clinical
Platelet disorders: Pathology review
Thrombocytopenia: Clinical
Bleeding disorders: Clinical
Thrombosis syndromes (hypercoagulability): Pathology review
Thrombophilia: Clinical
Peripheral vascular disease: Clinical
Venous thromboembolism: Clinical
Deep vein thrombosis and pulmonary embolism: Pathology review
Thrombolytics
Antiplatelet medications
Anticoagulants: Warfarin
Anticoagulants: Heparin
Anticoagulants: Direct factor inhibitors
Blood products and transfusion: Clinical
Vaccinations: Clinical
Pneumonia: Clinical
Abscesses
Infective endocarditis: Clinical
Skin and soft tissue infections: Clinical
Septic arthritis
Osteomyelitis
Fever of unknown origin: Clinical
Diarrhea: Clinical
Gastroenteritis
Clostridium difficile (Pseudomembranous colitis)
Urinary tract infections: Clinical
Sexually transmitted infections: Clinical
Meningitis, encephalitis and brain abscesses: Clinical
Clostridium tetani (Tetanus)
Clostridium botulinum (Botulism)
Salmonellosis
Shigella
Vibrio cholerae (Cholera)
Brucella
Mycobacterium tuberculosis (Tuberculosis)
Antituberculosis medications
Mycobacterium leprae
Treponema pallidum (Syphilis)
Leptospira
Upper respiratory tract infection
Pediatric upper airway conditions: Clinical
Pediatric lower airway conditions: Clinical
HIV (AIDS)
Herpes simplex virus
Varicella zoster virus
Herpesvirus medications
Epstein-Barr virus (Infectious mononucleosis)
Cytomegalovirus
Coccidioidomycosis and paracoccidioidomycosis
Aspergillus fumigatus
Mucormycosis
Plasmodium species (Malaria)
Antimalarials
Leishmania
Trypanosoma cruzi (Chagas disease)
Toxoplasma gondii (Toxoplasmosis)
Ascaris lumbricoides
Ancylostoma duodenale and Necator americanus
Strongyloides stercoralis
Enterobius vermicularis (Pinworm)
Anthelmintic medications
Bites and stings: Clinical
Cytomegalovirus infection after transplant (NORD)
Mechanisms of antibiotic resistance
Streptococcus pyogenes (Group A Strep)
Miscellaneous antifungal medications
Candida
Staphylococcus aureus
Pediatric infectious rashes: Clinical
ECG basics
ECG normal sinus rhythm
ECG rate and rhythm
ECG axis
ECG intervals
ECG QRS transition
ECG cardiac hypertrophy and enlargement
ECG cardiac infarction and ischemia
Atrial flutter
Atrial fibrillation
Premature atrial contraction
Atrioventricular nodal reentrant tachycardia (AVNRT)
Wolff-Parkinson-White syndrome
Ventricular tachycardia
Brugada syndrome
Premature ventricular contraction
Long QT syndrome and Torsade de pointes
Ventricular fibrillation
Atrioventricular block
Bundle branch block
Heart blocks: Pathology review
Pulseless electrical activity
Supraventricular arrhythmias: Pathology review
Ventricular arrhythmias: Pathology review
Heart failure
Heart failure: Pathology review
Heart failure: Clinical
Dilated cardiomyopathy
Restrictive cardiomyopathy
Hypertrophic cardiomyopathy
Cardiomyopathies: Clinical
Endocarditis
Myocarditis
Rheumatic heart disease
Tricuspid valve disease
Pulmonary valve disease
Mitral valve disease
Aortic valve disease
Valvular heart disease: Clinical
Pericarditis and pericardial effusion
Cardiac tamponade
Dressler syndrome
Pericardial disease: Clinical
Myocardial infarction
Coronary artery disease: Clinical
Renal artery stenosis
Hypertension: Clinical
Aortic aneurysms and dissections: Clinical
Pulmonary hypertension
Peripheral artery disease
Chronic venous insufficiency
Leg ulcers: Clinical
Congenital heart defects: Clinical
Lymphedema
Syncope: Clinical
Tuberculosis: Pathology review
Asthma: Clinical
Diffuse parenchymal lung disease: Clinical
Bronchiectasis
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Lung cancer: Clinical
Pleural effusion: Clinical
Anatomy clinical correlates: Pleura and lungs
Pleural effusion, pneumothorax, hemothorax and atelectasis: Pathology review
Sleep apnea
Respiratory distress syndrome: Pathology review
Acute respiratory distress syndrome: Clinical
Chronic obstructive pulmonary disease (COPD): Clinical
Pneumothorax: Clinical
Acute kidney injury: Clinical
Chronic kidney disease: Clinical
Nephritic and nephrotic syndromes: Clinical
Hypernatremia: Clinical
Hyponatremia: Clinical
Hyperkalemia: Clinical
Hypokalemia: Clinical
Parathyroid conditions and calcium imbalance: Clinical
Metabolic and respiratory alkalosis: Clinical
Metabolic and respiratory acidosis: Clinical
Kidney stones: Clinical
Esophageal disorders: Clinical
Esophageal surgical conditions: Clinical
Esophagitis: Clinical
Gastroesophageal reflux disease (GERD): Clinical
Peptic ulcers and stomach cancer: Clinical
Malabsorption syndromes: Pathology review
Inflammatory bowel disease: Clinical
Irritable bowel syndrome
Viral hepatitis: Clinical
Jaundice: Clinical
Cirrhosis: Clinical
Pancreatitis: Clinical
Alcohol-associated liver disease
Systemic lupus erythematosus (SLE): Clinical
Antiphospholipid syndrome
Rheumatoid arthritis: Clinical
Joint pain: Clinical
Scleroderma: Pathology review
Sjogren syndrome: Clinical
Seronegative arthritis: Clinical
Vasculitis: Clinical
Inflammatory myopathies: Clinical
Sarcoidosis
Gout and pseudogout: Pathology review
Antigout medications
Fibromyalgia
Hypopituitarism: Clinical
Thyroid nodules and thyroid cancer: Clinical
Hypothyroidism and thyroiditis: Clinical
Hyperthyroidism: Clinical
Adrenal masses and tumors: Clinical
Adrenal insufficiency: Clinical
Congenital adrenal hyperplasia: Clinical
MEN syndromes: Clinical
Cushing syndrome: Clinical
Pituitary adenomas and pituitary hyperfunction: Clinical
Diabetes mellitus: Clinical
Hypercholesterolemia: Clinical
Osteoporosis
Hemochromatosis
Seizures: Clinical
Cerebral vascular disease: Pathology review
Stroke: Clinical
Headaches: Clinical
Dementia and delirium: Clinical
Alzheimer disease
Parkinson disease
Hypokinetic movement disorders: Clinical
Hyperkinetic movement disorders: Clinical
Trigeminal neuralgia
Bell palsy
Multiple sclerosis
Guillain-Barre syndrome
Muscle weakness: Clinical
Myasthenia gravis
Lambert-Eaton myasthenic syndrome
Shock: Clinical
Disorders of consciousness: Clinical
Subarachnoid hemorrhage

Transcript

Watch video only

Content Reviewers

Multiple sclerosis is a demyelinating disease of the central nervous system, which includes the brain and the spinal cord.

Myelin is the protective sheath that surrounds the axons of neurons, allowing them to quickly send electrical impulses.

This myelin is produced by oligodendrocytes, which are a group of cells that support neurons.

In multiple sclerosis, demyelination happens when the immune system inappropriately attacks and destroys the myelin, which makes communication between neurons break down, ultimately leading to all sorts of sensory, motor, and cognitive problems.

Now, the brain, including the neurons in the brain, is protected by things in the blood by the blood brain barrier, which only lets certain molecules and cells through from the blood.

For immune cells like T and B cells that means having the right ligand or surface molecule to get through the blood brain barrier, this is kind of like having the a VIP pass to get into an exclusive club.

Once a T cell makes its way in it can get activated by something it encounters - in the case of multiple sclerosis, it’s activated by myelin.

Once the T-cell gets activated, it changes the blood brain barrier cells to express more receptors, and this allows immune cells to more easily bind and get in, it’s kind of like bribing the bouncer to let in a lot of people.

Now, multiple sclerosis is a type IV hypersensitivity reaction, or cell-mediated hypersensitivity. And this means that those myelin specific T-cells release cytokines like IL-1, IL-6, TNF-alpha, and interferon-gamma, and together dilate the blood vessels which allows more immune cells to get in, as well as directly cause damage to the oligodendrocytes.

The cytokines also attract B-cells and macrophages as part of the inflammatory reaction.

Those B-cells begin to make antibodies that mark the myelin sheath proteins, and then the macrophages use those antibody markers to engulf and destroy the oligodendrocytes.

Without oligodendrocytes, there’s no myelin to cover the neurons, and this leaves behind areas of scar tissue, also called plaques or sclera.

In multiple sclerosis, these immune attacks typically happen in bouts.

In other words, an autoimmune attack on the oligodendrocytes might happen, and then regulatory T cells will come in to inhibit or calm down the other immune cells, leading to a reduction in the inflammation.

Early on in multiple sclerosis, the oligodendrocytes will heal and extend out new myelin to cover the neurons, which is a process called remyelination.

Unfortunately, though, over time as the oligodendrocytes die off the remyelination stops and the damage becomes irreversible with the loss of axons.

Just like other autoimmune diseases, the exact cause of multiple sclerosis is unknown, but is linked to both genetic and environmental factors.

Genetic risk factors include being a woman and having genes that encode a specific type of immune molecule called HLA-DR2 which is used to identify and bind to foreign molecules.

Environmental risk factors might include infections as well as vitamin D deficiency, which is an interesting one because it might help explain why the rates of multiple sclerosis are higher at the northern and southern poles compared to the equator where there’s a lot more sunlight.

Together these genetic and environmental influences might lead to the body not killing off immune cells that target myelin.

So it turns out that there are four main types of multiple sclerosis based on the pattern of symptoms over time. To break this down, we can use this graph with time on the x-axis, where time refers to the lifespan of the individual, and disability on the y-axis.

The first, and by far the most common pattern of multiple sclerosis, is called relapsing-remitting multiple sclerosis or RRMS. This condition is what we just described, bouts of autoimmune attacks happening months, or even years, apart, and causing an increase in the level of disability.

For example, during a bout a person may lose some vision, but then it may be followed by improvement if there’s remyelination.

Unfortunately, though, more often than not, the remyelination process is not complete so there is often some residual disability that remains, and that means that with each attack, more and more of the central nervous system gets irreversibly damaged.

In the relapsing-remitting multiple sclerosis type there’s typically no increase in disability between bouts, so the line stays flat during that time.

Now, the second type is called secondary progressive multiple sclerosis or SPMS which initially is pretty similar to the relapse-remitting type, but over time the immune attack becomes constant which causes a steady progression of disability.

The third type is primary-progressive multiple sclerosis or PPMS, which is basically one constant attack on myelin which causes a steady progression of disability over a person’s lifetime.

The final type is progressive relapsing multiple sclerosis or PRMS, which is also one constant attack but this time there are bouts superimposed during which the disability increases even faster.

Specific symptoms varying a lot from person to person, and largely depend on the location of the plaques.

Key Takeaways

Multiple sclerosis is a progressive, demyelinating disease on the central nervous system, characterized by the destruction of myelin, the protective sheath surrounding nerve cells, as well as inflammation and scarring of nerve fibers.

Damage to these nerves disrupts the ability of parts of the nervous system to transmit impulses, resulting in a wide range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Symptoms vary widely, but they may include muscle weakness, fatigue, vision problems, balance and coordination problems, and problems with memory and thinking.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine" McGraw Hill Education/ Medical (2018)
  3. "Pathophysiology of Disease: An Introduction to Clinical Medicine 8E" McGraw-Hill Education / Medical (2018)
  4. "CURRENT Medical Diagnosis and Treatment 2020" McGraw Hill Professional (2019)
  5. "Multiple sclerosis" The Lancet (2008)
  6. "Defining the clinical course of multiple sclerosis: Results of an international survey" Neurology (1996)